D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 156 Citations 83,322 885 World Ranking 330 National Ranking 212
Best Scientists D-index 162 Citations 104,170 1,240 World Ranking 765 National Ranking 491

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His scientific interests lie mostly in Multiple myeloma, Cancer research, Internal medicine, Bone marrow and Bortezomib. His studies in Multiple myeloma integrate themes in fields like Hematology and Pathology. His Cancer research research integrates issues from Cell culture, Apoptosis, Protein kinase B, Cell growth and In vivo.

His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology, Surgery and Oncology. The Bone marrow study combines topics in areas such as Molecular biology, Stromal cell, Immune system and Peripheral blood mononuclear cell. His Bortezomib research is multidisciplinary, relying on both Proteasome inhibitor, Proteasome, Cancer cell, Signal transduction and Stem cell.

His most cited work include:

  • Signatures of mutational processes in human cancer (5372 citations)
  • Signatures of mutational processes in human cancer (5372 citations)
  • Antitumor activity of thalidomide in refractory multiple myeloma. (2200 citations)

What are the main themes of his work throughout his whole career to date?

Nikhil C. Munshi mainly focuses on Multiple myeloma, Cancer research, Internal medicine, Bortezomib and Bone marrow. The study incorporates disciplines such as Dexamethasone and Transplantation in addition to Multiple myeloma. Nikhil C. Munshi has included themes like Cell culture, Cell growth, Apoptosis, Cytotoxic T cell and In vivo in his Cancer research study.

His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology, Surgery and Oncology. His Bortezomib study combines topics from a wide range of disciplines, such as Proteasome inhibitor, Proteasome and Pharmacology. His Bone marrow research incorporates elements of Monoclonal antibody, Stromal cell and Cytokine.

He most often published in these fields:

  • Multiple myeloma (65.70%)
  • Cancer research (44.69%)
  • Internal medicine (31.69%)

What were the highlights of his more recent work (between 2017-2021)?

  • Multiple myeloma (65.70%)
  • Cancer research (44.69%)
  • Internal medicine (31.69%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Multiple myeloma, Cancer research, Internal medicine, Oncology and Computational biology. Multiple myeloma is represented through his Bortezomib and Lenalidomide research. His biological study spans a wide range of topics, including Cell culture, Immune system, Immunotherapy, Antigen and Bone marrow.

The concepts of his Cell culture study are interwoven with issues in Apoptosis, microRNA and Cell growth. His study in the field of Cancer, Progression-free survival, Newly diagnosed and Veterans Affairs also crosses realms of In patient. His Oncology study incorporates themes from Relapsed refractory, Refractory Multiple Myeloma, Dexamethasone and Minimal residual disease.

Between 2017 and 2021, his most popular works were:

  • Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma (422 citations)
  • Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. (149 citations)
  • Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma (130 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Nikhil C. Munshi spends much of his time researching Multiple myeloma, Cancer research, Internal medicine, Oncology and Computational biology. Nikhil C. Munshi combines subjects such as MEDLINE, APOBEC, Disease, Regulation of gene expression and Bone marrow with his study of Multiple myeloma. His Bone marrow research incorporates themes from Stromal cell, Downregulation and upregulation and Stem cell.

Nikhil C. Munshi has researched Cancer research in several fields, including Cell culture, Cell growth, Antigen, B-Cell Maturation Antigen and Immunotherapy. His study in the fields of Cancer, Lenalidomide, Progression-free survival and Retrospective cohort study under the domain of Internal medicine overlaps with other disciplines such as In patient. His studies deal with areas such as Maintenance therapy and Bortezomib as well as Lenalidomide.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio.
Nature (2013)

6684 Citations

Antitumor activity of thalidomide in refractory multiple myeloma.

Singhal S;Mehta J;Desikan R;Ayers D.
The New England Journal of Medicine (1999)

3339 Citations

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Robert C. Flanigan;Sydney E. Salmon;Brent A. Blumenstein;Scott I. Bearman.
The New England Journal of Medicine (2001)

2074 Citations

Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

E. Papaemmanuil;M. Cazzola;J. Boultwood;L. Malcovati.
The New England Journal of Medicine (2011)

1144 Citations

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie.
Lancet Oncology (2016)

1131 Citations

NF-κB as a Therapeutic Target in Multiple Myeloma *

Teru Hideshima;Dharminder Chauhan;Paul Richardson;Constantine Mitsiades.
Journal of Biological Chemistry (2002)

1124 Citations

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

Jan Krönke;Namrata D. Udeshi;Anupama Narla;Peter Grauman.
Science (2014)

1001 Citations

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

Paul G. Richardson;Edie Weller;Sagar Lonial;Andrzej J. Jakubowiak.
Blood (2010)

906 Citations

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications.

Nicholas Mitsiades;Constantine S. Mitsiades;Paul G. Richardson;Vassiliki Poulaki.
Blood (2003)

890 Citations

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

Nicholas Mitsiades;Constantine S. Mitsiades;Vassiliki Poulaki;Dharminder Chauhan.
Proceedings of the National Academy of Sciences of the United States of America (2002)

889 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Nikhil C. Munshi

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 423

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 355

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 324

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 311

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 264

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 255

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 227

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 222

Robert A. Kyle

Robert A. Kyle

Mayo Clinic

Publications: 207

Gareth J. Morgan

Gareth J. Morgan

New York University

Publications: 205

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 201

Sagar Lonial

Sagar Lonial

Emory University

Publications: 192

Evangelos Terpos

Evangelos Terpos

National and Kapodistrian University of Athens

Publications: 187

Martha Q. Lacy

Martha Q. Lacy

Mayo Clinic

Publications: 186

Irene M. Ghobrial

Irene M. Ghobrial

Harvard University

Publications: 184

Bart Barlogie

Bart Barlogie

Icahn School of Medicine at Mount Sinai

Publications: 183

Trending Scientists

Vladimir Druskin

Vladimir Druskin

Worcester Polytechnic Institute

Kazem Zare

Kazem Zare

University of Tabriz

Seema Agarwal

Seema Agarwal

University of Bayreuth

Gerd Buntkowsky

Gerd Buntkowsky

TU Darmstadt

Chanjuan Xi

Chanjuan Xi

Tsinghua University

Víctor Sánchez-Cordero

Víctor Sánchez-Cordero

National Autonomous University of Mexico

Aaron Klug

Aaron Klug

MRC Laboratory of Molecular Biology

Niko E. C. Verhoest

Niko E. C. Verhoest

Ghent University

Stefan Voorspoels

Stefan Voorspoels

Flemish Institute for Technological Research

Brian E. Cairns

Brian E. Cairns

University of British Columbia

John O'Keefe

John O'Keefe

University College London

Achim Hoerauf

Achim Hoerauf

University Hospital Bonn

Helene F. Rosenberg

Helene F. Rosenberg

National Institutes of Health

Thomas M. Chused

Thomas M. Chused

National Institutes of Health

Eva Hellström-Lindberg

Eva Hellström-Lindberg

Karolinska University Hospital

Something went wrong. Please try again later.